Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Showing 20 of 0 results

Not applicableStudy completedNCT03137264
What this trial is testing

Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT02713204
What this trial is testing

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 365
Post-approval studies (Phase 4)UnknownNCT02462304
What this trial is testing

To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

Who this might be right for
Diabetic Macula Edema
The University of Hong Kong 60
Early research (Phase 1)WithdrawnNCT06341647
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Adenocarcinoma
GC Cell Corporation
Early research (Phase 1)Active Not RecruitingNCT05567185
What this trial is testing

Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsReceptors, Fibroblast Growth Factor
Janssen Pharmaceutical K.K. 5
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Post-approval studies (Phase 4)Study completedNCT02821520
What this trial is testing

Initial Versus Delayed PDT Combination With Conbercept in PCV

Who this might be right for
Polypoidal Choroidal Vasculopathy
The Eye Hospital of Wenzhou Medical University 80
Testing effectiveness (Phase 2)UnknownNCT02407366
What this trial is testing

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
People's Hospital of Guangxi Zhuang Autonomous Region 80
Very early researchStudy completedNCT06282731
What this trial is testing

The Changes of Urine Growth Factors Level

Who this might be right for
Benign Prostatic Hyperplasia
En Chu Kong Hospital 74
Early research (Phase 1)Not Yet RecruitingNCT04933422
What this trial is testing

CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)

Who this might be right for
Glioblastoma
Crimson Biopharm Inc. 72
Large-scale testing (Phase 3)Study completedNCT00079066
What this trial is testing

Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer

Who this might be right for
Colorectal CancerQuality of Life
NCIC Clinical Trials Group 572
Testing effectiveness (Phase 2)Ended earlyNCT05215951
What this trial is testing

Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC

Who this might be right for
Lung Cancer
AstraZeneca 4
Large-scale testing (Phase 3)Study completedNCT03206151
What this trial is testing

CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149
What this trial is testing

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Who this might be right for
NSCLC
Allist Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)Ended earlyNCT02720185
What this trial is testing

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Who this might be right for
Breast NeoplasmsTriple Negative Breast Neoplasms
University of Wisconsin, Madison 5
Early research (Phase 1)Looking for participantsNCT04886726
What this trial is testing

PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Versus Host Disease
Henry Ford Health System 18
Early research (Phase 1)UnknownNCT02211443
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 21
Not applicableLooking for participantsNCT05400590
What this trial is testing

Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

Who this might be right for
Aniridia
Fondation Ophtalmologique Adolphe de Rothschild 24
Not applicableStudy completedNCT05709158
What this trial is testing

Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

Who this might be right for
Breast Cancer
Pfizer 4,184
Not applicableUnknownNCT05560035
What this trial is testing

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

Who this might be right for
Cervical CancerMetastatic Cancer
General Hospital of Ningxia Medical University 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation